Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Reduced plasma levels of asymmetric di-methylarginine (ADMA) in patients with alcohol dependence normalize during withdrawal.

Frieling H, Leitmeier V, Haschemi-Nassab M, Kornhuber J, Rhein M, Bleich S, Hillemacher T.

Eur Neuropsychopharmacol. 2012 Nov;22(11):836-40. doi: 10.1016/j.euroneuro.2012.03.010. Epub 2012 Apr 14.

PMID:
22507687
3.
4.

Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease.

van Guldener C, Nanayakkara PW, Stehouwer CD.

Clin Chem Lab Med. 2007;45(12):1683-7. Review.

PMID:
17937610
5.

Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects.

Holven KB, Haugstad TS, Holm T, Aukrust P, Ose L, Nenseter MS.

Br J Nutr. 2003 Mar;89(3):359-63.

PMID:
12628031
6.

Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.

Kumagai H, Sakurai M, Takita T, Maruyama Y, Uno S, Ikegaya N, Kato A, Hishida A.

Am J Kidney Dis. 2006 Nov;48(5):797-805.

PMID:
17059999
7.

Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.

Krzyzanowska K, Mittermayer F, Krugluger W, Schnack C, Hofer M, Wolzt M, Schernthaner G.

Atherosclerosis. 2006 Nov;189(1):236-40. Epub 2006 Jan 18.

PMID:
16414052
8.

Asymmetric dimethylarginine, homocysteine and renal function--is there a relation?

Siroká R, Trefil L, Rajdl D, Racek J, Rusnáková H, Cibulka R, Eiselt J, Filipovský J.

Clin Chem Lab Med. 2005;43(10):1147-50.

PMID:
16197312
10.

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine.

Stühlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JP.

Circulation. 2001 Nov 20;104(21):2569-75.

11.

The role of homocysteine, asymmetric dimethylarginine and nitric oxide in pre-eclampsia.

Demir B, Demir S, Pasa S, Guven S, Atamer Y, Atamer A, Kocyigit Y.

J Obstet Gynaecol. 2012 Aug;32(6):525-8. doi: 10.3109/01443615.2012.693985.

PMID:
22779953
12.
13.

An assessment of the potential value of elevated homocysteine in predicting alcohol-withdrawal seizures.

Bleich S, Bayerlein K, Hillemacher T, Degner D, Kornhuber J, Frieling H.

Epilepsia. 2006 May;47(5):934-8.

14.

Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism.

Wilhelm J, Bayerlein K, Hillemacher T, Reulbach U, Frieling H, Kromolan B, Degner D, Kornhuber J, Bleich S.

J Neural Transm (Vienna). 2006 Mar;113(3):357-63. Epub 2005 Jul 6.

PMID:
15997414
15.

Alterations of homocysteine serum levels during alcohol withdrawal are influenced by folate and riboflavin: results from the German Investigation on Neurobiology in Alcoholism (GINA).

Heese P, Linnebank M, Semmler A, Muschler MA, Heberlein A, Frieling H, Stoffel-Wagner B, Kornhuber J, Banger M, Bleich S, Hillemacher T.

Alcohol Alcohol. 2012 Sep-Oct;47(5):497-500. doi: 10.1093/alcalc/ags058. Epub 2012 May 29.

PMID:
22645037
16.

Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.

Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC.

J Am Soc Nephrol. 1999 Mar;10(3):594-600.

17.
18.

Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction.

Korandji C, Zeller M, Guilland JC, Vergely C, Sicard P, Duvillard L, Gambert P, Moreau D, Cottin Y, Rochette L.

Clin Biochem. 2007 Jan;40(1-2):66-72. Epub 2006 Aug 30.

PMID:
17020756
19.

Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.

Maas R, Dentz L, Schwedhelm E, Thoms W, Kuss O, Hiltmeyer N, Haddad M, Klöss T, Standl T, Böger RH.

Crit Care Med. 2007 Aug;35(8):1876-81.

PMID:
17581491
20.

Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.

Wang J, Sim AS, Wang XL, Salonikas C, Naidoo D, Wilcken DE.

Atherosclerosis. 2006 Feb;184(2):383-8. Epub 2005 Jun 6.

PMID:
15939423

Supplemental Content

Support Center